Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
about
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in bloodHLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expressionCD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138.MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.The immunology of Epstein-Barr virus infectionEpstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformationEx vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions.Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineageCorrelation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's diseaseEpstein-Barr virus and the lacrimal gland pathology of Sjögren's syndromeEpstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latencyUnusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution.Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequencesIdentification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.Hierarchy of Epstein-Barr virus-specific cytotoxic T-cell responses in individuals carrying different subtypes of an HLA allele: implications for epitope-based antiviral vaccinesAnalysis of the tumorigenic potential of common marmoset lymphoblastoid cells expressing a constitutively activated c-myc gene.T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism.Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine developmentIdentification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignanciesAn alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigenDevelopment of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosisEndogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis.Immune regulation in Epstein-Barr virus-associated diseasesDistinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.Identification of a glucocorticoid-responsive element in Epstein-Barr virus.An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformantsHost cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell linesHuman herpesviruses: a consideration of the latent state.Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
P2860
Q24564697-45D8EFC8-5FCB-4FA3-B5D7-5D4E45523C9AQ24805330-B34D3D79-DEDB-4BE3-9C11-BE334ADD3BABQ30452144-83591FB0-78DC-42A2-92BC-AA0E5449646EQ33782440-5049331A-3B0B-48D6-976E-F9F8BF871079Q33783532-2C6D2F6D-6064-42B0-89EE-7FD9594907F5Q33878986-A7949214-0ADD-40A4-8374-3A0DC16BCA42Q34048911-6BE584E4-6CFB-48F3-9149-712E506C0FA7Q34225567-CC951D7F-2E91-42FE-B4EC-09BEB75CBD99Q34324039-C78CBD04-D045-4679-A45F-F656DBEBBF7DQ34975513-F157CFA7-3595-48AB-B9F6-D194C833B4E0Q35149684-7EEBB343-3287-4455-A59A-65D95389D17CQ35621782-6943A96C-53F8-4A6F-9A76-9DD37C2A8E6FQ35831215-AF36D9B4-D51E-4430-8041-0ABCDD3A3BA7Q35831438-2DA4BFF8-A838-41BC-A717-377D71662F7CQ35832930-0B531A55-71B0-4CCD-8D6A-3726CE357965Q35833217-E90A4A5F-5B79-49C4-9984-65B50FC3574CQ35859094-76574E9A-9FC5-40BE-93B5-8C0354D6469DQ35865306-26A54F8B-5042-433F-8F92-68D7C779B242Q35873998-2412E471-FC73-4AC8-A010-F8C8F643F382Q35895384-EC1B24AB-FCC5-4953-97CC-C639DEBEE30DQ35976927-FC6806BA-8BB9-4CF1-9BCB-F50E549C1DDAQ36229993-6647E196-2DD1-482D-9C8B-4CF3856AD9C0Q36231451-E533052C-F3F6-4B6A-8119-9BBC2B77C153Q36231550-D5825434-4249-456B-9C12-5105360E5403Q36362943-665C9848-1F85-4813-83F2-51FDE482905CQ36365637-6E879360-97E7-47A3-9946-7FB9A9B09771Q36367562-A3556FDA-EA3C-4C70-89E1-76AF8CFF261DQ36399179-8F6C2DB0-FC16-4B79-A485-E9C0ED6B43C4Q36466103-FD43BDDD-C72E-485E-9EF5-9433F7AB09EBQ36669953-E8FB76B8-6BAA-434D-A817-54D566BAF517Q36781303-394539BD-23B1-4477-9AD6-9C9B883751B0Q36791391-71E50BA6-3BCA-4976-B361-AA3BA6888D6AQ36802798-2A8EDA8F-0FC3-4942-84DE-97C44FF4B2B3Q36805227-0C18840E-D457-4F82-AB8C-92F8B703A6E3Q36812687-406F816A-50EE-48F0-821F-E5997B7F3CC7Q36828590-CBBC5AC2-0E78-4994-B1E4-0A3633118939Q36873046-34DCEF59-2A39-42F6-BA3C-5EC8ACDC3FEBQ36922798-B79B9C78-6470-493C-8E22-6E9A864ED882Q37055693-E319395D-36D6-42F0-9690-7A48B3863DA4Q37557660-BFE4BC75-7CC0-4831-BDF7-1229A9BEC5EB
P2860
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Cytotoxic T-cell clones discri ...... tein-Barr virus transformants.
@en
Cytotoxic T-cell clones discri ...... tein-Barr virus transformants.
@nl
type
label
Cytotoxic T-cell clones discri ...... tein-Barr virus transformants.
@en
Cytotoxic T-cell clones discri ...... tein-Barr virus transformants.
@nl
prefLabel
Cytotoxic T-cell clones discri ...... tein-Barr virus transformants.
@en
Cytotoxic T-cell clones discri ...... tein-Barr virus transformants.
@nl
P2093
P356
P1433
P1476
Cytotoxic T-cell clones discri ...... tein-Barr virus transformants.
@en
P2093
P2888
P304
P356
10.1038/331719A0
P407
P577
1988-02-01T00:00:00Z
P6179
1031238224